InBody Co.,Ltd (KOSDAQ:041830)
57,600
-700 (-1.20%)
Sep 11, 2026, 3:30 PM KST
InBody Co.,Ltd Revenue
InBody Co.,Ltd had revenue of 73.25B KRW in the quarter ending June 30, 2026, with 30.41% growth. This brings the company's revenue in the last twelve months to 263.89B, up 21.30% year-over-year. In the year 2025, InBody Co.,Ltd had annual revenue of 233.95B with 14.42% growth.
Revenue (ttm)
263.89B
Revenue Growth
+21.30%
P/S Ratio
2.91
Revenue / Employee
925.94M
Employees
285
Market Cap
768.76B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 233.95B | 29.48B | 14.42% |
| Dec 31, 2024 | 204.46B | 34.11B | 20.03% |
| Dec 31, 2023 | 170.35B | 10.35B | 6.47% |
| Dec 31, 2022 | 160.00B | 22.17B | 16.08% |
| Dec 31, 2021 | 137.84B | 30.71B | 28.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 738.76B |
| Seegene | 509.27B |
| i-SENS | 326.19B |
| T&L Co., Ltd. | 175.16B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| L&C BIO Co.,LTD | 116.30B |
| SEERS | 97.05B |